GC-derived exosomal circMAN1A2 promotes cancer progression and suppresses T-cell antitumour immunity by inhibiting FBXW11-mediated SFPQ degradation

Abstract Background Exosomes, as extracellular membrane vesicles, play important roles in intercellular communication and can influence tumour progression. Circular RNAs (circRNAs) have been reported in various malignancies and are also important components of exosomes. However, the role of exosomal...

Full description

Saved in:
Bibliographic Details
Main Authors: Yikai Shen, Jie Lin, Tianlu Jiang, Xusheng Shen, Ying Li, Yiwang Fu, Penghui Xu, Lang Fang, Zetian Chen, Hongxin Huang, Yiwen Xia, Zekuan Xu, Linjun Wang
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Online Access:https://doi.org/10.1186/s13046-025-03288-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585323458068480
author Yikai Shen
Jie Lin
Tianlu Jiang
Xusheng Shen
Ying Li
Yiwang Fu
Penghui Xu
Lang Fang
Zetian Chen
Hongxin Huang
Yiwen Xia
Zekuan Xu
Linjun Wang
author_facet Yikai Shen
Jie Lin
Tianlu Jiang
Xusheng Shen
Ying Li
Yiwang Fu
Penghui Xu
Lang Fang
Zetian Chen
Hongxin Huang
Yiwen Xia
Zekuan Xu
Linjun Wang
author_sort Yikai Shen
collection DOAJ
description Abstract Background Exosomes, as extracellular membrane vesicles, play important roles in intercellular communication and can influence tumour progression. Circular RNAs (circRNAs) have been reported in various malignancies and are also important components of exosomes. However, the role of exosomal circRNAs in gastric cancer (GC) progression has not been completely clarified. Methods The exosomal circRNAs enriched in GC were identified using exosomal circRNA sequencing. The biological function of circMAN1A2 in GC was investigated using a series of in vitro and in vivo experiments. PKH-67 staining was used to label the exosomes. The molecular mechanism of exosomal circMAN1A2 was investigated via mass spectrometry, immunoprecipitation, Western blot, and single-cell RNA-sequencing data analyses. Results In our study, we determined that circMAN1A2 (hsa_circ_0000118) was enriched in GC-derived exosomes. Higher circMAN1A2 expression was related to poor survival in GC patients (HR = 2.917, p = 0.0120). Exosomal circMAN1A2 promoted GC progression in vitro and in vivo and suppressed the antitumour activity of T cells. Moreover, circMAN1A2 bound to SFPQ in GC cells and T cells, promoting the G1/S phase transition of the cell cycle in GC cells while inhibiting the activation of the T cell receptor signalling pathway in T cells to decrease antitumour activity. Mechanistically, circMAN1A2 competed with FBXW11 for binding to SFPQ, preventing FBXW11-mediated k48-linked ubiquitination and SFPQ protein degradation, thereby stabilizing SFPQ expression. Conclusions Our work confirms the critical role of exosomal circMAN1A2 in the progression and immunosuppression of GC. This novel axis of circMAN1A2-SFPQ provides new insights into exosomal circRNA-based GC diagnostic and therapeutic strategies.
format Article
id doaj-art-eb1ea939c9554f519e9a32f11c3b6b45
institution Kabale University
issn 1756-9966
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Journal of Experimental & Clinical Cancer Research
spelling doaj-art-eb1ea939c9554f519e9a32f11c3b6b452025-01-26T12:57:54ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662025-01-0144112810.1186/s13046-025-03288-9GC-derived exosomal circMAN1A2 promotes cancer progression and suppresses T-cell antitumour immunity by inhibiting FBXW11-mediated SFPQ degradationYikai Shen0Jie Lin1Tianlu Jiang2Xusheng Shen3Ying Li4Yiwang Fu5Penghui Xu6Lang Fang7Zetian Chen8Hongxin Huang9Yiwen Xia10Zekuan Xu11Linjun Wang12Gastric Cancer Center, The First Affiliated Hospital of Nanjing Medical UniversityGastric Cancer Center, The First Affiliated Hospital of Nanjing Medical UniversityThe Affiliated Wuxi People’s Hospital of Nanjing Medical University, Wuxi Medical Center, Nanjing Medical University, Wuxi People’s HospitalGastric Cancer Center, The First Affiliated Hospital of Nanjing Medical UniversityGastric Cancer Center, The First Affiliated Hospital of Nanjing Medical UniversityGastric Cancer Center, The First Affiliated Hospital of Nanjing Medical UniversityGastric Cancer Center, The First Affiliated Hospital of Nanjing Medical UniversityGastric Cancer Center, The First Affiliated Hospital of Nanjing Medical UniversityGastric Cancer Center, The First Affiliated Hospital of Nanjing Medical UniversityGastric Cancer Center, The First Affiliated Hospital of Nanjing Medical UniversityGastric Cancer Center, The First Affiliated Hospital of Nanjing Medical UniversityGastric Cancer Center, The First Affiliated Hospital of Nanjing Medical UniversityGastric Cancer Center, The First Affiliated Hospital of Nanjing Medical UniversityAbstract Background Exosomes, as extracellular membrane vesicles, play important roles in intercellular communication and can influence tumour progression. Circular RNAs (circRNAs) have been reported in various malignancies and are also important components of exosomes. However, the role of exosomal circRNAs in gastric cancer (GC) progression has not been completely clarified. Methods The exosomal circRNAs enriched in GC were identified using exosomal circRNA sequencing. The biological function of circMAN1A2 in GC was investigated using a series of in vitro and in vivo experiments. PKH-67 staining was used to label the exosomes. The molecular mechanism of exosomal circMAN1A2 was investigated via mass spectrometry, immunoprecipitation, Western blot, and single-cell RNA-sequencing data analyses. Results In our study, we determined that circMAN1A2 (hsa_circ_0000118) was enriched in GC-derived exosomes. Higher circMAN1A2 expression was related to poor survival in GC patients (HR = 2.917, p = 0.0120). Exosomal circMAN1A2 promoted GC progression in vitro and in vivo and suppressed the antitumour activity of T cells. Moreover, circMAN1A2 bound to SFPQ in GC cells and T cells, promoting the G1/S phase transition of the cell cycle in GC cells while inhibiting the activation of the T cell receptor signalling pathway in T cells to decrease antitumour activity. Mechanistically, circMAN1A2 competed with FBXW11 for binding to SFPQ, preventing FBXW11-mediated k48-linked ubiquitination and SFPQ protein degradation, thereby stabilizing SFPQ expression. Conclusions Our work confirms the critical role of exosomal circMAN1A2 in the progression and immunosuppression of GC. This novel axis of circMAN1A2-SFPQ provides new insights into exosomal circRNA-based GC diagnostic and therapeutic strategies.https://doi.org/10.1186/s13046-025-03288-9Gastric cancerExosomescircMAN1A2Antitumour immunity
spellingShingle Yikai Shen
Jie Lin
Tianlu Jiang
Xusheng Shen
Ying Li
Yiwang Fu
Penghui Xu
Lang Fang
Zetian Chen
Hongxin Huang
Yiwen Xia
Zekuan Xu
Linjun Wang
GC-derived exosomal circMAN1A2 promotes cancer progression and suppresses T-cell antitumour immunity by inhibiting FBXW11-mediated SFPQ degradation
Journal of Experimental & Clinical Cancer Research
Gastric cancer
Exosomes
circMAN1A2
Antitumour immunity
title GC-derived exosomal circMAN1A2 promotes cancer progression and suppresses T-cell antitumour immunity by inhibiting FBXW11-mediated SFPQ degradation
title_full GC-derived exosomal circMAN1A2 promotes cancer progression and suppresses T-cell antitumour immunity by inhibiting FBXW11-mediated SFPQ degradation
title_fullStr GC-derived exosomal circMAN1A2 promotes cancer progression and suppresses T-cell antitumour immunity by inhibiting FBXW11-mediated SFPQ degradation
title_full_unstemmed GC-derived exosomal circMAN1A2 promotes cancer progression and suppresses T-cell antitumour immunity by inhibiting FBXW11-mediated SFPQ degradation
title_short GC-derived exosomal circMAN1A2 promotes cancer progression and suppresses T-cell antitumour immunity by inhibiting FBXW11-mediated SFPQ degradation
title_sort gc derived exosomal circman1a2 promotes cancer progression and suppresses t cell antitumour immunity by inhibiting fbxw11 mediated sfpq degradation
topic Gastric cancer
Exosomes
circMAN1A2
Antitumour immunity
url https://doi.org/10.1186/s13046-025-03288-9
work_keys_str_mv AT yikaishen gcderivedexosomalcircman1a2promotescancerprogressionandsuppressestcellantitumourimmunitybyinhibitingfbxw11mediatedsfpqdegradation
AT jielin gcderivedexosomalcircman1a2promotescancerprogressionandsuppressestcellantitumourimmunitybyinhibitingfbxw11mediatedsfpqdegradation
AT tianlujiang gcderivedexosomalcircman1a2promotescancerprogressionandsuppressestcellantitumourimmunitybyinhibitingfbxw11mediatedsfpqdegradation
AT xushengshen gcderivedexosomalcircman1a2promotescancerprogressionandsuppressestcellantitumourimmunitybyinhibitingfbxw11mediatedsfpqdegradation
AT yingli gcderivedexosomalcircman1a2promotescancerprogressionandsuppressestcellantitumourimmunitybyinhibitingfbxw11mediatedsfpqdegradation
AT yiwangfu gcderivedexosomalcircman1a2promotescancerprogressionandsuppressestcellantitumourimmunitybyinhibitingfbxw11mediatedsfpqdegradation
AT penghuixu gcderivedexosomalcircman1a2promotescancerprogressionandsuppressestcellantitumourimmunitybyinhibitingfbxw11mediatedsfpqdegradation
AT langfang gcderivedexosomalcircman1a2promotescancerprogressionandsuppressestcellantitumourimmunitybyinhibitingfbxw11mediatedsfpqdegradation
AT zetianchen gcderivedexosomalcircman1a2promotescancerprogressionandsuppressestcellantitumourimmunitybyinhibitingfbxw11mediatedsfpqdegradation
AT hongxinhuang gcderivedexosomalcircman1a2promotescancerprogressionandsuppressestcellantitumourimmunitybyinhibitingfbxw11mediatedsfpqdegradation
AT yiwenxia gcderivedexosomalcircman1a2promotescancerprogressionandsuppressestcellantitumourimmunitybyinhibitingfbxw11mediatedsfpqdegradation
AT zekuanxu gcderivedexosomalcircman1a2promotescancerprogressionandsuppressestcellantitumourimmunitybyinhibitingfbxw11mediatedsfpqdegradation
AT linjunwang gcderivedexosomalcircman1a2promotescancerprogressionandsuppressestcellantitumourimmunitybyinhibitingfbxw11mediatedsfpqdegradation